跳至主要内容
临床试验/IRCT2013031011885N2
IRCT2013031011885N2已完成3 期

Evaluating the efficacy of adding Donepezil to a selective serotonin re-uptake inhibitor (Sertraline) in the treatment of major depressive disorder

Vice chancellor for research, Mazandaran University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 years 至 55 years(—)
性别
All

入选标准

  • Entry: All outpatients with Major Depressive Disorder based on DSM-IV-TR in the age range of 25-55 year old who refer to psychiatric clinic in Zare hospital or Tooba clinic. Exclusion criteria: Catatonia; Acute suicidal idea; Major past medical history; Endocrine diseases; Chronic cardiovascular diseases; Respiratory diseases; Hepatic failure; Renal failure; Active peptic ulcer, Acute infectious diseases; Malignancies; Neurolgic disorders; Axis I psychiatric disorders except of Major depressive disorder; Axis II psychiatric disorders; Family history of bipolar disorder; Concomitant use of psychiatric drugs except for Antidepressants; Outside the age range of 25-55; refuse to participate in the study; Pregnancy, Breastfeeding; Lack of contraception in women of childbearing age.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Mazandaran University of Medical Sciences

相似试验

Efficacy of Donepezil in the treatment of Major... | 临床试验